Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib. (Record no. 19277746)

MARC details
000 -LEADER
fixed length control field 01541 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515193451.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1569-8041
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/annonc/mdp472
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Overkleeft, E N M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100224
245 00 - TITLE STATEMENT
Title Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of oncology : official journal of the European Society for Medical Oncology
Date of publication, distribution, etc. Jan 2010
300 ## - PHYSICAL DESCRIPTION
Extent 184-5 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Letter
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiogenesis Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzenesulfonates
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Renal Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Kidney Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nephrotic Syndrome
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Niacinamide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phenylurea Compounds
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyridines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrroles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sorafenib
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sunitinib
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goldschmeding, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Reekum, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Voest, E E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Verheul, H M W
773 0# - HOST ITEM ENTRY
Title Annals of oncology : official journal of the European Society for Medical Oncology
Related parts vol. 21
-- no. 1
-- p. 184-5
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/annonc/mdp472">https://doi.org/10.1093/annonc/mdp472</a>
Public note Available from publisher's website

No items available.